Masked Functional Groups
Masked Functional Groups is a prodrug design strategy in which biologically active but potentially toxic functional groups are temporarily modified through chemical derivatization to reduce reactivity or toxicity, thereby improving pharmacokinetic properties and enabling controlled activation in vivo.
60
Publications
2.7K
Citations
249
Authors
104
Institutions
Publications per year
2017–2026
16
60
<i>N</i><sup>α</sup>-2-Mercaptobenzylamine-Assisted Chemical Ligation
John Offer, Philip E. Dawson · Organic Letters · 1999 · 106 citations
1–5 of 60
249
2
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 249
104
Scripps Research Institute
San Diego, United States
2 h-index
7 publications
427 citations

Centre National de la Recherche Scientifique
Paris, France
2 h-index
14 publications
312 citations
ETH Zurich
Zurich, Switzerland
2 h-index
5 publications
313 citations
National Research Council
Rome, Italy
2 h-index
6 publications
177 citations
Northeast Forestry University
Harbin, China
1 h-index
3 publications
57 citations

McLean Hospital
Belmont, United States
1 h-index
5 publications
340 citations
Central European Institute of Technology – Masaryk University
Brno, Czechia
1 h-index
3 publications
93 citations
Commissariat à l'Énergie Atomique et aux Énergies Alternatives
Paris, France
1 h-index
2 publications
152 citations
1–8 of 104
JOC · 7 publications · 177 citations
7
h-index
OL · 5 publications · 256 citations
5
h-index
JACS · 4 publications · 220 citations
4
h-index
ChemComm · 3 publications · 107 citations
3
h-index
2 publications · 273 citations
2
h-index
1–5